Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dylan Hansen

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Rheumatology (Oxford, England)|January 28, 2026
Evaluation of a screening algorithm to detect systemic sclerosis-related myopathyVandana Bhushan, Vidya Limaye, Dylan Hansen, et al.
The Australasian Journal of Dermatology|July 7, 2026
Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort StudyVivien Wai Yun Lai, Dylan Hansen, Maryam Tabesh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional TherapyKate Gregory, Dylan Hansen, Ross Penglase, et al.
Pulmonary Circulation|June 10, 2026
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension-Results From the SPHInX StudyMandana Nikpour, Alicia Calderone, Susanna M Proudman, et al.
Arthritis Care & Research|October 18, 2024
Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis CohortLaura Taylor, Dylan Hansen, Kathleen Morrisroe, et al.
Rheumatology (Oxford, England)|February 27, 2026
Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvementLaura Ross, Andrew T Burns, André La Gerche, et al.
Lupus Science & Medicine|September 19, 2024
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosusYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
ACR Open Rheumatology|February 27, 2025
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus CohortYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
Arthritis Care & Research|September 16, 2025
Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically ActiveYanjie Hao, Dylan Hansen, Rangi Kandane-Rathnayake, et al.
Arthritis Care & Research|April 6, 2026
Mucocutaneous disease activity and damage accrual in systemic lupus erythematosus: analyses from the Asia-Pacific Lupus Collaboration longitudinal cohort studyAmanda M Saracino, Yanjie Hao, Dylan Hansen, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Rheumatology (Oxford, England)|January 28, 2026
Evaluation of a screening algorithm to detect systemic sclerosis-related myopathyVandana Bhushan, Vidya Limaye, Dylan Hansen, et al.
The Australasian Journal of Dermatology|July 7, 2026
Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort StudyVivien Wai Yun Lai, Dylan Hansen, Maryam Tabesh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional TherapyKate Gregory, Dylan Hansen, Ross Penglase, et al.
Pulmonary Circulation|June 10, 2026
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension-Results From the SPHInX StudyMandana Nikpour, Alicia Calderone, Susanna M Proudman, et al.
Arthritis Care & Research|October 18, 2024
Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis CohortLaura Taylor, Dylan Hansen, Kathleen Morrisroe, et al.
Rheumatology (Oxford, England)|February 27, 2026
Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvementLaura Ross, Andrew T Burns, André La Gerche, et al.
Lupus Science & Medicine|September 19, 2024
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosusYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
ACR Open Rheumatology|February 27, 2025
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus CohortYanjie Hao, Dylan Hansen, Worawit Louthrenoo, et al.
Arthritis Care & Research|September 16, 2025
Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically ActiveYanjie Hao, Dylan Hansen, Rangi Kandane-Rathnayake, et al.
Arthritis Care & Research|April 6, 2026
Mucocutaneous disease activity and damage accrual in systemic lupus erythematosus: analyses from the Asia-Pacific Lupus Collaboration longitudinal cohort studyAmanda M Saracino, Yanjie Hao, Dylan Hansen, et al.
Pageof 6